the vaccine – Page 16 – Communicable Diseases Research

[Change in serum IgG antibody during the recovery stage of Omicron variant infection in children: an analysis of 110 cases]

[소아 오미크론 변이체 감염 회복기 혈청 IgG 항체 변화 : 110건 분석]

Article

Published on 2022-07-152022-09-11
Journal: Zhongguo dang dai er ke za zhi = Chinese journal o [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

InjectMeAI-Software Module of an Autonomous Injection Humanoid

InjectMeAI-자율주입 휴머노이드의 소프트웨어 모듈

Article

Published on 2022-07-152022-09-11
Journal: Sensors (Basel, Switzerland) [Category] COVID19(2023년), SARS, 변종, 치료기술,

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis

SARS-CoV-2 Omicron에 대한 백신 효능: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2022-07-132022-09-11
Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI Against Analysis B.1.1.529 BNT162b2 booster Booster vaccine caused Cochrane Library COVID-19 COVID-19 vaccine COVID-19 vaccines database databases dose Effectiveness evaluate examined inception ineffectiveness Infection Meta-analysis Moderna mRNA omicron Omicron variant protective effect provide provided random-effects model reduce Respiratory illness review SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines searched significantly South Africa systemic the SARS-CoV-2 the vaccine vaccination Vaccinations Vaccine variant was performed was used Web of Science
[DOI] 10.3389/fpubh.2022.940956 PMC 바로가기 [Article Type] Meta-Analysis

Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study

COVID-19 등재 백신 효과의 도시 모니터링, 평가 및 적용: 건강 코드 블록체인 연구

Article

Published on 2022-07-132022-09-11
Journal: BMJ Open [Category] 변종,

[키워드] aggravate Algorithm analysed Analysis Asymptomatic average basic reproduction number calculate city Complete conditions Contact cooperation country COVID-19 decrease deviation Effectiveness eight ENhance epidemiological Epidemiological investigation Epidemiology evaluate greater Health Health policy herd immunity Immunity increase Incubation period index infection rate information measure MONITOR mutant virus not decreased outcome Patient Primary outcome Primary outcomes promote promoted proportion protective effect reduced regions respond second significantly Simulation statistical symptomatic the vaccine this system transmitted urban urban population vaccination vaccination rate Vaccination strategy Vaccine Vaccines variant Variation virus weight
[DOI] 10.1136/bmjopen-2021-057281 PMC 바로가기 [Article Type] Article

Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays

중증이 아닌 환자의 외래 추적 관찰 및 백신 접종 후 다양한 시점에서 항-SARS-CoV-2 IgG 검출을 위한 측면 유동 면역분석의 기술적 성능: 효소 및 화학발광 면역분석과의 비교

Article

Published on 2022-07-132022-09-12
Journal: Revista do Instituto de Medicina Tropical de São [Category] MERS, 진단,

[키워드] acute phase Analysis analyzed anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibody antibody production Blood booster dose chemiluminescent immunoassay children chose CLIA collected composed Coronavirus infections COVID-19 decrease diagnosed donors Efficiency eight enzyme expected Finger prick Follow-up healthcare healthy immunoassay immunochromatographic assay Infection lateral flow lateral flow immunoassay LFIA likelihood ratio Non-severe case NPV operator participant Pediatric patient performed positive PPV produced RT-PCR sensitivity serological Serological assay serum sample serum samples Seven specificity study group tested the antibody the vaccine three group true negative vaccination Variation volunteers Whole blood
[DOI] 10.1590/S1678-9946202264049 PMC 바로가기 [Article Type] Article

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022

이탈리아의 5-11세 아동에서 SARS-CoV-2 감염 및 중증 COVID-19에 대한 BNT162b2 백신의 효과: 2022년 1월-4월의 후향적 분석

Article

Published on 2022-07-092022-09-11
Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI Admission Analysis appear approval B.1.1.529 BNT162b2 children completion COVID-19 death deaths decrease defined diagnosed Diagnosis dose doses effective Effectiveness eligible epidemiological for inclusion hospitalisation hospitalisations individual Infection information intensive care units Italian Italy less material municipality National of BNT162b2 Older Omicron variant peaked Pfizer-BioNTech previous diagnosis public health residence retrospective Retrospective analysis SARS-COV-2 infection severe COVID-19 study period Surveillance the vaccine translation vaccinated against COVID-19 vaccination Vaccine were excluded
[DOI] 10.1016/S0140-6736(22)01185-0 PMC 바로가기 [Article Type] Article

Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern

S1에 TLR7 작용제가 내장된 아주반트-단백질 접합 백신은 SARS-CoV-2 및 우려 변종에 대한 강력한 면역을 유도합니다

Article

Published on 2022-07-082022-09-11
Journal: ACS Infectious Diseases [Category] COVID19(2023년), SARS, 변종,

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2

SARS-CoV-2에 대한 드럭뱅크 실험 화합물의 인-실리코 스크리닝 및 분자 역학 시뮬레이션

Article

Published on 2022-07-082022-09-11
Journal: Molecules [Category] COVID19(2023년), SARS, 치료제,

[키워드] ADME Area Bank can be used Community Compound conditions Coronaviridae family docking drug Drug Bank Dynamics Effectiveness experimental drug Experimental drugs followed by group In-vitro Infection infection rate inhibitor molecular molecular docking molecular dynamics Molecular dynamics simulation Mutation performed Precision reason reduce replication-transcription complex replication-transcription complex. Research RNA RNA polymerase RNA-dependent RNA polymerase SARS-CoV-2 screened Screening Severe acute respiratory syndrome Simulation small molecule Small molecules stability surface surface area the Coronaviridae the patient the SARS-CoV-2 the vaccine the WHO thiophosphate thymidine Vaccine Virtual screening virus
[DOI] 10.3390/molecules27144391 PMC 바로가기 [Article Type] Article

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

캐나다 온타리오주 장기요양원에서 오미크론 변이에 대한 covid-19 mRNA 백신 4차 접종의 효과: 음성 설계 연구 테스트

Article

Published on 2022-07-062022-09-11
Journal: The BMJ [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% confidence interval BNT162b2 Canada Care Chain Reaction Characteristics Comorbidities Control death dominant dose doses Effectiveness Hospital admission Infection Logistic regression long term mRNA mRNA COVID-19 vaccines mRNA vaccine mRNA-1273 multivariable logistic regression Older Omicron variant outcome outcomes polymerase chain polymerase chain reaction positive recipient reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test Seven symptomatic symptomatic infection Test test negative test result tested the vaccine vaccination Vaccine vaccine dose was used
[DOI] 10.1136/bmj-2022-071502 PMC 바로가기 [Article Type] Article

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

영국에서 두 번째 백신 접종 후 COVID-19 백신 돌파구를 경험한 인구 설명: OpenSAFELY의 코호트 연구

Article

Published on 2022-07-052022-09-11
Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI Admission analyses approval can not Care Characteristics Chronic kidney disease circulating cohort study concerning conducted COVID-19 COVID-19 vaccine Critical care database death described Describing determine dialysis effective EHR EHR data England follow-up time group groups haematological malignancy helping higher risk highest Hospital admissions Immunocompromised incidence rate increase individual Kidney disease majority malignancy median Mild NHS omicron Omicron variant OpenSAFELY Patient positive registry data reported retrospective cohort study risk routine clinical data SARS-CoV-2 test SARS-CoV-2 variant SARS-CoV-2 variants second vaccination secondary care the vaccine Transplant vaccinated against COVID-19 vaccinated individuals Vaccine Vaccine breakthrough variant variants while
[DOI] 10.1186/s12916-022-02422-0 PMC 바로가기 [Article Type] Article